approval · primary record
FOSDENOPTERIN HYDROBROMIDE
FDA · NDA · 2026-05-26
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2026-05-26 |
| Brand | NULIBRY |
| Sponsor | SENTYNL THERAPS INC |
| Route | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:34:58.494Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:FOSDENOPTERIN HYDROBROMIDE:2026-05-26
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.